Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD

A. Papadopoulos, K. Bartziokas, A. Haniotou, K. Kostikas (Athens, Greece)

Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Session: Monitoring exacerbations of airway diseases
Session type: Thematic Poster Session
Number: 911
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Papadopoulos, K. Bartziokas, A. Haniotou, K. Kostikas (Athens, Greece). Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD. Eur Respir J 2011; 38: Suppl. 55, 911

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum uric acid levels among COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 435s
Year: 2003

Serum uric acid levels among patients with COPD exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Assessment of serum uric acid in COPD exacerbations
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA
Source: Eur Respir J 2006; 28: Suppl. 50, 408s
Year: 2006

Serum uric acid as a predictor of mortality and future exacerbations of COPD
Source: Eur Respir J 2014; 43: 43-53
Year: 2004



Blood plasma levels of ascorbic acid in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 674s
Year: 2006

Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

The role of uric acid to creatinine ratio as predictor marker during pulmonary embolism
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021



Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018
Year: 2019



Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations?
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Serum and pulmonary uric acid in pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2000332; 10.1183/13993003.00332-2020
Year: 2021



Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Urine uric acid excretion in obese and nonobese children with obstructive sleep-disordered breathing
Source: Annual Congress 2008 - Sleep apnoea in childhood
Year: 2008

Total serum bilirubin levels are not related to the severity of COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


Comparative analysis of light‘s criteria, albumin gradient, alkaline phosphatase, total cholesterol, total bilirubin and uric acid measurements for differentiation of pleural exudates from transudates
Source: Eur Respir J 2006; 28: Suppl. 50, 580s
Year: 2006

Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Uric acid and bronchial oxidative stress in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 634s
Year: 2006

Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020